Executive record

Christopher Van Tuyl

Chief Legal Officer and Corporate Secretary at Immunovant, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:christopher-van-tuyl-imvtVersion: public-0As of: 2026-09-30

Not yet claimed9 published Claims3 sources
  • Executive

Key Claims

Biography

Mr. Van Tuyl has served as Chief Legal Officer and Corporate Secretary since December 2024, previously serving in the same role at Dermavant Sciences for over six years. He also held legal roles at Sacks Tierney, Fidelity National Information Services, and Rayonier, Inc.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Legal Officer and Corporate Secretary · Immunovant, Inc.
  2. 2025 to end not publishedExecutive title: Chief Legal Officer and Corporate Secretary · Organization not publishedIMVT DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec def 14a · Source published: Jul 22, 2026 · Retrieved: Sep 6, 2026

    Supports 2 claims
    • Professional Role: Chief Legal Officer and Corporate Secretary at Immunovant, Inc. · Claim reviewed: Sep 6, 2026
    • Executive title: Executive title: Chief Legal Officer and Corporate Secretary · Claim reviewed: Sep 6, 2026

  2. IMVT DEF 14A executive officers

    sec filing · Source published: Jul 9, 2025 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Immunovant Inc · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Legal Officer and Corporate Secretary · Claim reviewed: Sep 6, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  3. IMVT executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
    • Executive company: Executive at Immunovant Inc · Claim reviewed: May 15, 2026
    • Executive function: Legal Governance (GENERAL_COUNSEL) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Chief Legal Officer and Corporate Secretary · Claim reviewed: Sep 6, 2026